"All for one, one for all": Evaluating composite endpoints in clinical trials

Canadian Pharmacists Journal

Volumn 141, Issue 1, 2008, Pages 28-31

  Gidda, Sunny ^a   Tejani, Aaron ^a  

^a FRASER HEALTH AUTHORITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME;

EID: 38949097532     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X(2008)141[28:AFOOFA]2.0.CO;2     Document Type: Article

References (10)

1. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, et al. Validity of composite end points in clinical trials. BMJ 2005;330:594-6.
2. Schulz KF, Grimes DA. Multiplicity in randomized trials I: endpoints and treatments. Lancet 2005;365:1591-5.
3. Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Med J Aust 2004;180:289-91.
4. Freemantle N, Calvert M, Wood J, et al. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003;289:2554-9.
5. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.
6. Niewoehner DE, Erbland ML, Deupree RR, et al. Effect of systematic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999;340:1941-7.
7. Crowther CA, Hiller JE, Moss JR, et al; Australian Carbohydrate Intolerance Study in Pregnant Women (AHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86.
8. Lewis EJ, Hunsicker LG, Clarke WR, et al; Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
9. Courtney C, Farrell D, Gray R, et al; AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004;363:2105-15.
10. Montori VM, Busse JW, Permanyer-Miralda G, et al. How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump? ACP J Club 2005;143:A8.